本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

8.21
+0.01000.12%
盤前8.01-0.2000-2.44%04:20 EDT
成交量:75.11萬
成交額:619.41萬
市值:11.22億
市盈率:205.25
高:8.38
開:8.21
低:8.20
收:8.20
資料載入中...
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]